In treating social anxiety disorder, which medication is commonly prescribed to patients with this condition?

Questions 75

ATI RN

ATI RN Test Bank

ATI Mental Health Practice A Questions

Question 1 of 5

In treating social anxiety disorder, which medication is commonly prescribed to patients with this condition?

Correct Answer: B

Rationale: Sertraline is a selective serotonin reuptake inhibitor (SSRI) commonly used to treat social anxiety disorder. SSRIs are a first-line pharmacological treatment for social anxiety disorder due to their effectiveness in reducing anxiety symptoms by increasing serotonin levels in the brain, which helps regulate mood and emotions. Methylphenidate is a stimulant primarily used in attention deficit hyperactivity disorder (ADHD) but not in social anxiety disorder. Lithium is typically used in bipolar disorder, while haloperidol is an antipsychotic medication more commonly used in conditions like schizophrenia. Therefore, the correct choice for treating social anxiety disorder is Sertraline (B).

Question 2 of 5

A patient with posttraumatic stress disorder (PTSD) is prescribed prazosin. The nurse understands that this medication is used to treat which symptom of PTSD?

Correct Answer: B

Rationale: Prazosin is a medication often prescribed to manage nightmares in patients with PTSD. It works by blocking the action of adrenaline on specific receptors, which helps in reducing the intensity and frequency of nightmares. While flashbacks, hypervigilance, and depression are also common symptoms of PTSD, prazosin is specifically indicated for nightmares associated with the disorder. Flashbacks are typically addressed through therapies like cognitive-behavioral therapy, hypervigilance may be managed through counseling and coping strategies, and depression may necessitate antidepressant medications or therapy tailored for depression.

Question 3 of 5

A patient with generalized anxiety disorder (GAD) is prescribed escitalopram. The nurse should educate the patient that the full therapeutic effect of this medication may take:

Correct Answer: D

Rationale: Escitalopram, an SSRI used in treating generalized anxiety disorder, typically takes 6-8 weeks to achieve its full therapeutic effect. While some improvement may be noticed earlier, the maximum benefit is usually experienced after this timeframe. Options A, B, and C are incorrect because they underestimate the time required for escitalopram to reach its full effectiveness. Educating patients about the realistic timeline for medication effectiveness is crucial in managing expectations and ensuring adherence to the prescribed treatment.

Question 4 of 5

In assessing a patient for signs of serotonin syndrome, which of the following symptoms would be consistent with this condition?

Correct Answer: B

Rationale: Serotonin syndrome is characterized by a triad of symptoms: hypertension, tachycardia, and hyperthermia. Therefore, the correct answer is B. Hypotension, bradycardia, and hypothermia (choice A) are not typical findings in serotonin syndrome. Hypotension, tachycardia, and hypothermia (choice C) are also not consistent with serotonin syndrome. Hypertension, bradycardia, and hyperthermia (choice D) do not align with the characteristic symptoms of serotonin syndrome. Recognizing the key symptoms of serotonin syndrome is crucial for prompt identification and intervention to prevent serious complications.

Question 5 of 5

A patient with major depressive disorder is started on venlafaxine. Which class of antidepressant does this medication belong to?

Correct Answer: D

Rationale: Venlafaxine is classified as a serotonin-norepinephrine reuptake inhibitor (SNRI). SNRIs work by increasing the levels of both serotonin and norepinephrine in the brain, which helps alleviate symptoms of depression. This mechanism of action distinguishes SNRIs from other classes of antidepressants like SSRIs, TCAs, and MAOIs, making venlafaxine an effective choice for patients with major depressive disorder. Therefore, the correct answer is D. Choice A, SSRIs, primarily target serotonin reuptake only. Choice B, TCAs, work by inhibiting the reuptake of norepinephrine and serotonin, but they are not as selective as SNRIs. Choice C, MAOIs, inhibit the enzyme monoamine oxidase, leading to increased levels of various neurotransmitters, including serotonin and norepinephrine, but they are typically used as second- or third-line agents due to dietary restrictions and potential side effects.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions